🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareCommunity poll: What medication are you currently on? Page 2

Community poll: What medication are you currently on?

mike_mod Sat, May 23, 2026 at 10:07 AM 10 replies 536 viewsPage 2 of 2
Dr.ObesityLA
VIP Member
3,567
19,876
Dec 2023
Los Angeles, CA
May 23, 2026 at 10:14 PM#6
BethLabQueen said:
Read four things before the headline number.

I read this differently from BethLabQueen, on substance rather than tone. I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them. The results probably generalise, and "probably" should be stated as an assumption rather than dropped.

44 14zoe_NC, Dr.ObesityLA, NurseKim_ATL and 41 others
Reply Quote Save Share Report
raj_cambridge
Member
489
2,123
Jun 2024
Cambridge, MA
May 24, 2026 at 3:01 AM#7
mike_mod said:
My own curve sits about four points below the published mean and I spent two months assuming that meant something was wrong with me or with my…
mike_mod said:
...regarding the trial evidence...

I think this is an underappreciated point. To expand on it with some data:

A recent meta-analysis of 15 RCTs (n=12,300) found that the trial evidence was associated with a clinically meaningful effect size across diverse patient populations[1].

The NNT was 12, which is comparable to antihypertensives for stroke reduction. That's a strong clinical argument for this approach.

43 13DoseLogDan, SleepFixSam, PurityPaulOR and 40 others
Reply Quote Save Share Report
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
May 24, 2026 at 7:48 AM#8
Dr.ObesityLA said:
I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them.

Bayesian meta-analysis perspective on the trial evidence: traditional frequentist meta-analyses report point estimates and confidence intervals. Bayesian approaches provide probability distributions that are more intuitive for clinical decision-making.

For example: "There is a 98.5% probability that semaglutide 2.4mg produces >10% weight loss vs placebo" is more actionable than "RR 3.4, 95% CI 2.8-4.1, p<0.001."

The the trial evidence evidence is strong under both frameworks, but Bayesian analysis better communicates the degree of certainty for individual patient counseling.

Last edited: May 24, 2026 at 12:48 PM
42 12josh_phd_bmore, roxy_nash, tony_orlando and 39 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
dan_philly
Member
456
2,123
Jul 2024
Philadelphia, PA
May 24, 2026 at 12:35 PM#9

Following on from InsuranceTom — and this may be the naive question:

What would you measure differently if you were starting again?

41 11Dr.CardioMD, EndoResFellow, PharmacoVig_BOS and 38 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
May 25, 2026 at 11:32 AM#10

Closing the loop on my own question.

Follow-up: I read the paper rather than the summary and the qualifier I was missing was in the second paragraph of the results.

Last edited: May 25, 2026 at 1:32 PM
7 5PurityPaulOR, MaxMetOK, MounjBrad and 4 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register